Trials / Conditions / Respiratory Syncytial Virus Immunization
Respiratory Syncytial Virus Immunization
5 registered clinical trials studyying Respiratory Syncytial Virus Immunization.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related NCT07164430 | Nicola Irwin | — |
| Active Not Recruiting | Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncyti NCT07071558 | Sanofi | Phase 1 |
| Active Not Recruiting | Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Ra NCT06824207 | Sanofi Pasteur, a Sanofi Company | — |
| Active Not Recruiting | Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Na NCT06686654 | Sanofi Pasteur, a Sanofi Company | Phase 1 / Phase 2 |
| Completed | Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adu NCT05639894 | Sanofi Pasteur, a Sanofi Company | Phase 1 / Phase 2 |